Open access
Oct 2026
Discovery of YA8026, an optimized human constitutive androstane receptor activator from a novel ML241-derived scaffold.
A new non-CITCO chemotype for hCAR activation is established and YA8026 is identified as a promising lead compound for further development following the discovery of a structurally distinct class of hCAR activators based on the 2,4-diaminopyrimidine scaffold of ML241.
Yong Ai, Lin-Hao Li, Caitlin Lynch et al.
· European journal of medicina... · 0 citations